AAAAAA
Results:
1-7
|
Results: 7
Authors:
Wingard, JR
White, MH
Anaissie, E
Buell, D
Citation: Jr. Wingard et al., Mortality rates in comparative trials of formulations of amphotericin B - Reply, CLIN INF D, 33(4), 2001, pp. 583-584
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome (R)): A 91-day study in rats, PHARM RES, 17(12), 2000, pp. 1494-1502
Authors:
Nash, RA
Antin, JH
Karanes, C
Fay, JW
Avalos, BR
Yeager, AM
Przepiorka, D
Davies, S
Petersen, FB
Bartels, P
Buell, D
Fitzsimmons, W
Anasetti, C
Storb, R
Ratanatharathorn, V
Citation: Ra. Nash et al., Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, BLOOD, 96(6), 2000, pp. 2062-2068
Authors:
Bekersky, I
Fielding, RM
Buell, D
Lawrence, I
Citation: I. Bekersky et al., Lipid-based amphotericin B formulations: from animals to man, PHARM SCI T, 2(6), 1999, pp. 230-236
Authors:
Bekersky, I
Boswell, GW
Hiles, R
Fielding, RM
Buell, D
Walsh, TJ
Citation: I. Bekersky et al., Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome (R)) in beagle dogs, PHARM RES, 16(11), 1999, pp. 1694-1701
Authors:
Boswell, GW
Buell, D
Bekersky, I
Citation: Gw. Boswell et al., AmBisome (liposomal amphotericin B): A comparative review (vol 38, pg 583,1998), J CLIN PHAR, 39(4), 1999, pp. 428-428
Authors:
Bekersky, I
Buell, D
Boswell, G
Citation: I. Bekersky et al., ABELCET (R) treatment - Reply, J CLIN PHAR, 39(4), 1999, pp. 428-428
Risultati:
1-7
|